The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlative analysis of phase II trial of olaparib and durvalumab in patients with IDH-mutated cholangiocarcinoma.
 
Xin Wang
Consulting or Advisory Role - SERVIER
 
Erica Tsang
Honoraria - AstraZeneca; Guardant Health; Incyte
Research Funding - Amgen; AstraZeneca; Coherus Biosciences (Inst); Loxo/Lilly; Pfizer (Inst); Roche/Genentech; Torl Biotherapeutics
 
Yosef Ellenbogen
No Relationships to Disclose
 
Vikas Patil
No Relationships to Disclose
 
Valentin Sotov
No Relationships to Disclose
 
Grainne O'Kane
Honoraria - AstraZeneca; Incyte; MSD Oncology; Roche; Servier/Pfizer; Zymeworks
Consulting or Advisory Role - AstraZeneca Canada; Incyte; Roche; Servier
Research Funding - AstraZeneca
Travel, Accommodations, Expenses - MSD; Novartis; Takeda
 
Jennifer Knox
Honoraria - Astellas Pharma; AstraZeneca; Incyte; Ipsen
Consulting or Advisory Role - AstraZeneca/MedImmune; Incyte; Ipsen
Research Funding - AstraZeneca; Ipsen; Merck
Expert Testimony - AstraZeneca; Incyte
 
Ben Wang
No Relationships to Disclose
 
Gelareh Zadeh
No Relationships to Disclose
 
Eric Chen
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Daiichi Sankyo/Astra Zeneca; Eisai; GlaxoSmithKline; Incyte; Merck; Roche; Takeda
Research Funding - 1Globe Health Institute (Inst); AstraZeneca/MedImmune (Inst); BNT (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Mirati Therapeutics (Inst); Nouscom (Inst); Ono Pharmaceutical (Inst); Pfizer; Repare Therapeutics (Inst); Roche Canada (Inst)